Latest filing published 27 Aug 2026 for Anterix Inc., €1.2M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Christopher Guttman-McCabe, listed as senior executive, appears in our data through filings on Anterix Inc. shares, published by SEC (Form 4). Between 5 May 2021 and 25 August 2026, the trades on record add up to 42 filings.
The open-market record consists of 16 sales worth €10.8M, with no purchase. The amount is not disclosed for 4 filings. Besides market trades, the filings include 19 share grants and 7 option exercises. So far in 2026, the count stands at no purchases and 15 sales.
The record was last updated on 27 August 2026 with an option exercise (€1.2M) in Anterix Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 42 declarations